techno Oncolytic viruses

Oncolytic viruses

With its oncolytic viruses, Transgene attacks tumors on several fronts.

Oncolytics selectively multiply in cancer cells (a process called cell lysis) and indirectly trigger the activation of the immune system against the tumor.


The mechanism of action of oncolytic viruses

 

Transgene believes that oncolytic viruses, by integrating complimentary mechanisms of action, can become an efficacious therapy for multiple cancers.

TG6002
colorectal cancer (Phase I/IIa)

More

BT-001 
VV GM-CSF Anti-CTLA-4)
solid tumors (Phase I/IIA)

More

Transgene sa
400 Boulevard Gonthier d’Andernach - Parc d'Innovation - CS80166
67405 Illkirch Graffenstaden Cedex - France |
Tel. : + 33 (0) 3 88 27 91 00

 

© 2021 Transgene - All rights reserved
Terms of use - Credits